{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • Internal Series
  • On-Demand Activities
  • CE Planning Process
  • Calendar
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

11th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Featuring The Fenmore Lectureship and The Redlich Lectureship


11th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Featuring The Fenmore Lectureship and The Redlich Lectureship Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • Exhibitor Registration
  • View Exhibits
Add to Calendar 11th Annual New Therapeutics in Oncology: The Road to Personalized Medicine Featuring The Fenmore Lectureship and The Redlich Lectureship 11/11/2022 1:30:00 PM 11/12/2022 4:30:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/oncologycme2022 Description: This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignan... Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard false MM/DD/YYYY


Date & Location
Friday, November 11, 2022, 1:30 PM - Saturday, November 12, 2022, 4:30 PM PST, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA

Target Audience
Specialties - Hematology, Internal Medicine, Oncology, Pain Management, Radiation Oncology, Surgery

Overview
This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, next generation CAR-T cell therapies and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy.

Objectives
  1. Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of cancer patients
  2. Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
  3. Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
  4. Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
  5. Anticipate the needs and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

Registration

Physicians: $129
Pharmacists: $79
Industry: $229
Healthcare professionals-Nurses, Residents/Fellows, Medical students, C-S associated healthcare professionals: Free

Refund Policy
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.  


Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

Health and Safety Protocol
Before registering for this event, please read our Health and Safety Protocol for current requirements pertaining to attending in-person events.



Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 9.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (9.50 hours), Non-Physician AMA Attendance (9.50 hours)


Keywords: LIVEAMA



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Razelle Kurzrock, MD
Medical College of Wisconsin
Course Director
Independent ContractorResearcher-Biological Dynamics|Independent ContractorResearcher-Boehringer Ingelheim|Independent ContractorResearcher-Debiopharm|Independent ContractorResearcher-Foundation Medicine|Independent ContractorResearcher-Genentech|Independent ContractorResearcher-Grifols|Independent ContractorResearcher-Guardant|Independent ContractorResearcher-Incyte|Independent ContractorResearcher-Konica Minolta|Independent ContractorResearcher-Medimmune|Independent ContractorResearcher-Merck Serono|Independent ContractorResearcher-Omniseq|Independent ContractorResearcher-Pfizer|Independent ContractorResearcher-Sequenom|Independent ContractorResearcher-Takeda|Independent ContractorResearcher-TopAlliance|Consultant-Actuate Therapeutics|Consultant-AstraZeneca|Consultant- Bicara Therapeutics|Consultant-Biological Dynamics|Consultant-Daiichi Sankyo, Inc.|Consultant-EISAI|Consultant-EOM Pharmaceuticals|Consultant-Iylon|Consultant-Merck|Consultant-NeoGenomics|Consultant- Neomed|Consultant-Pfizer|Consultant-Prosperdtx|Consultant-Roche|Consultant-TD2 Volastra|Consultant-Turning Point Therapeutics|Consultant-X-Biotech
Faculty Photos
Alain Mita, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Faculty Photos
Monica M. Mita, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Robert A. Figlin, MD
Cedars-Sinai
Faculty
Nothing to disclose
Faculty Photos
Andrew E. Hendifar, MD
Cedars-Sinai
Faculty
Consultant-Ipsen (Relationship has ended)|Consultant-Amgen|Advisor-Merck and Company, Inc.
Faculty Photos
Patricia LoRusso, DO
Yale School of Medicine
Faculty
Advisor-Five Prime (Relationship has ended)|Advisor-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Advisor-Agenus (Relationship has ended)|Advisor-IQVIA (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-ImmunoMet (Relationship has ended)|Advisor-Black Diamond (Relationship has ended)|Advisor-GlaxoSmithKline (Relationship has ended)|Advisor-QED Therapeutics (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Advisor-EMD Serono (Relationship has ended)|Advisor-Shattuck (Relationship has ended)|Advisor-Astellas (Relationship has ended)|Advisor-Silverback (Relationship has ended)|Advisor-MacroGenics (Relationship has ended)|Advisor-Kineta (Relationship has ended)|Advisor-Molecular Templates|Advisor-ABL Bio (Relationship has ended)|Consultant-SK Life (Relationship has ended)|Advisor-STCube (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-I-MAB|Consultant-I-MAB|Advisor-Seagen (Relationship has ended)|Advisor-imCheck (Relationship has ended)|Advisor-Relay Therapeutics (Relationship has ended)|Advisor-Stemline (Relationship has ended)|Advisor-Compass BADX (Relationship has ended)|Advisor-Mekanist (Relationship has ended)|Advisor-Mersana|Advisor-BAKX Therapeutics|StockPrivate-BAKX Therapeutics|Advisor-Scenic Biotech|Advisor-Qualigen|Consultant-Roivant|Advisor-NeuroTrials
Inderjit Mehmi, MD
Cedars-Sinai
Faculty
Nothing to disclose
Faculty Photos
Ronald B. Natale, MD
Cedars-Sinai
Faculty
PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-Johnson and Johnson|PrincipalNamedInvestigator-Merck and Company, Inc.|PrincipalNamedInvestigator-Millennium Pharmaceuticals, Inc. (Relationship has ended)|PrincipalNamedInvestigator-Pfizer, Inc.
Faculty Photos
Sukhmani Padda, MD
Cedars-Sinai
Faculty
PrincipalNamedInvestigator-Epicentrx (Relationship has ended)|PrincipalNamedInvestigator-Bayer Corporation (Relationship has ended)|PrincipalNamedInvestigator-Boehringer Ingelheim Vetmedica GmbH (Relationship has ended)|Advisor-Janssen Pharmaceuticals|Advisor-Sanofi Genzyme|Advisor-Mirati Therapeutics|Speaker-OncLive (Relationship has ended)|Consultant-Jazz Pharmaceuticals (Relationship has ended)|Consultant-Physician Education Resource (Relationship has ended)|Advisor-Genentech, Inc. (Relationship has ended)|Independent ContractorResearcher-Nanobiotix (Relationship has ended)|Advisor-AstraZeneca
Edwin M Posadas, MD
Cedars-Sinai
Faculty
Speaker-Bayer Corporation|Advisor-cytolumina|Speaker-Myovant
Karen Reckamp, MD
Cedars-Sinai
Faculty
Consultant-Amgen (Relationship has ended)|Consultant-Mirati (Relationship has ended)|Consultant-Janssen|Consultant-Genentech, Inc.|Consultant-EMD Serono (Relationship has ended)|Consultant-GlaxoSmithKline|Consultant-Merck KGA (Relationship has ended)|Consultant-Blueprint (Relationship has ended)|PrincipalNamedInvestigator-Elevation Oncology|PrincipalNamedInvestigator-Daiichi Sankyo|PrincipalNamedInvestigator-Blueprint|PrincipalNamedInvestigator-Calithera (Relationship has ended)|PrincipalNamedInvestigator-Genentech, Inc.|PrincipalNamedInvestigator-Janssen
Faculty Photos
Joshua Sasine, MD, PhD
Cedars-Sinai
Faculty
Speaker-Kite Pharma (Relationship has ended)|Other: Video for internal Amgen use, not to be shown outside of Amgen. -Amgen (Relationship has ended)|Speaker-Bristol-Myers Squibb (Relationship has ended)
Faculty Photos
Eric Vail, MD
Cedars-Sinai
Faculty
Speaker-Bayer Corporation|Speaker-Eli Lilly and Company|Speaker-Johnson and Johnson|Speaker-AstraZeneca|Consultant-PierianDx|Consultant-Thermo Fisher Scientific|Consultant-Illumina|Speaker-Tempus|Independent ContractorResearcher-LungLifeAI
Faculty Photos
Robert Vescio, MD
Cedars-Sinai
Faculty
Speaker-Bristol-Myers Squibb|Speaker-GlaxoSmithKline|Speaker-Amgen|Speaker-Karyopharm|Speaker-Janssen
Faculty Photos
Yuan Yuan, MD, PhD
Cedars Sinai Cancer
Faculty
Consultant-Novartis AG|Speaker-Merck and Company, Inc.|Speaker-Eisai, Inc. (Relationship has ended)|Speaker-Gilead|Speaker-Pfizer, Inc.|Speaker-AstraZeneca|Speaker-Daiichi Sankyo|PrincipalNamedInvestigator-Daiichi Sankyo (Relationship has ended)|PrincipalNamedInvestigator-Merck and Company, Inc.|PrincipalNamedInvestigator-Genentech, Inc.|Speaker-Genentech, Inc.|PrincipalNamedInvestigator-Novartis AG

Friday, November 11, 2022
 
General Session: November 11, 2022

Chairs: Ronald B. Natale, MD and Alain Mita, MD
Registration and Check-In
1:30PM - 2:00PM
Welcome/Introduction
2:00PM - 2:10PM
Adoptive T cell therapies.
2:10PM - 2:50PM
Inderjit Mehmi, MD
Expert Updates for Treatment of Prostate Cancer
2:50PM - 3:20PM
Edwin M Posadas, MD
Question & Answer
3:20PM - 3:30PM
Edwin M Posadas, MD
Molecular Testing for Personalized Cancer Therapy: Successes and Opportunities for Improvement
3:30PM - 4:00PM
Eric Vail, MD
Q&A
4:00PM - 4:10PM
Eric Vail, MD
New Drugs on the Horizon
4:10PM - 4:40PM
Monica M. Mita, MD
Reception
4:40PM - 5:30PM
Saturday, November 12, 2022
 
Morning General Session: November 12, 2022

Chairs: Andrew E Hendifar, MD
Check-in and Breakfast
7:30AM - 8:00AM
Welcome/Introduction
8:00AM - 8:10AM
New Drugs Approved in 2022 and their Mechanism of Action
8:10AM - 8:40AM
Alain Mita, MD
Q&A
8:40AM - 8:50AM
Alain Mita, MD
Targeted Therapies for Lung Cancer: Personalizing Treatment
8:50AM - 9:20AM
Ronald B. Natale, MD
Q&A
9:20AM - 9:30AM
Ronald B. Natale, MD
Myeloma Treatment: What are the New Standards?
9:30AM - 10:00AM
Robert Vescio, MD
Q&A
10:00AM - 10:10AM
Robert Vescio, MD
Break
10:10AM - 10:15AM
 
Mini-Symposia: Neoadjuvant and Adjuvant Immunotherapy: Are we Curing more Patients?

Chairs: Razelle Kurzrock, MD and Karen Reckamp, MD
Lung Cancer
10:15AM - 10:35AM
Sukhmani Padda, MD
Breast Cancer
10:35AM - 10:55AM
Yuan Yuan, MD, PhD
GI Malignancies
10:55AM - 11:15AM
Andrew E. Hendifar, MD
Neoadjuvant therapy in Melanoma
11:15AM - 11:35AM
Inderjit Mehmi, MD
Q&A
11:35AM - 12:00PM
 
Afternoon General Session: November 12, 2022

Chairs: Robert A Figlin, MD and Alain Mita, MD
Lunch
12:00PM - 1:00PM
Keynote Speaker: Optimal Dose Determination in Phase I Clinical Trials
1:00PM - 1:45PM
Patricia LoRusso, DO
Q&A
1:45PM - 2:00PM
Patricia LoRusso, DO
Updates for the treatment of Her-2 positive breast cancer
2:00PM - 2:30PM
Monica M. Mita, MD
Q&A
2:30PM - 2:40PM
Monica M. Mita, MD
Expert Updates for NHL/Leukemia Treatment
2:40PM - 3:10PM
Joshua Sasine, MD, PhD
Q&A
3:10PM - 3:20PM
Joshua Sasine, MD, PhD

Exhibit space is now sold out.  Thank you for your interest and we hope to see you next year!


Contact Us:
CME Office
Cedars-Sinai
8700 Beverly Blvd., CME
Los Angeles, CA 90048
Phone: 3104235548
Email: [email protected]
Website: https://cedars.cloud-cme.com/oncologycme



Exhibitor Packages

Exhibitor Package - Gold Level Supporter Price: $2500.00
Includes:
  • Recognition as a Gold Level Supporter Exhibitor
  • (1) 6ft Table Top, includes 2 chairs
  • Number of Exhibitor Badges: 2
  • (2) Complimentary breakfast, lunch and refreshment
  • Exhibit Location: Assigned Table Space

Deadline for order commitment is 11/10/2022 11:00:00 PM.

Exhibitor Package - Gold Level Booth Staff Price: $0.00
Includes:
  • Recognition as a Exhibit Booth Staff Exhibitor
  • Number of Exhibitor Badges: 2
  • Exhibit Location: Assigned Table Space

Deadline for order commitment is 11/9/2022 12:00:00 AM.

11th Oncology Posting by Cedars-Sinai CME


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2025 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization.